AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 201 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,109 | -12.5% | 44,805 | +0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,268 | +17.5% | 44,783 | -4.7% | 0.00% | 0.0% |
| Q1 2023 | $1,079 | -18.2% | 46,979 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,319 | -99.9% | 46,979 | -1.2% | 0.00% | -25.0% |
| Q3 2022 | $1,344,000 | -41.3% | 47,543 | -54.0% | 0.00% | -33.3% |
| Q2 2022 | $2,291,000 | -84.9% | 103,319 | -70.5% | 0.01% | -82.9% |
| Q4 2020 | $15,199,000 | +64.5% | 350,768 | +32.9% | 0.04% | +40.0% |
| Q3 2020 | $9,238,000 | -36.3% | 263,939 | -2.6% | 0.02% | -41.9% |
| Q2 2020 | $14,496,000 | +51.5% | 271,058 | +0.5% | 0.04% | +26.5% |
| Q1 2020 | $9,568,000 | -25.4% | 269,671 | +0.3% | 0.03% | -8.1% |
| Q4 2019 | $12,832,000 | +65.2% | 268,733 | +12.1% | 0.04% | +54.2% |
| Q3 2019 | $7,769,000 | – | 239,789 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |